These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33315051)

  • 41. Schlemm's canal and primary open angle glaucoma: correlation between Schlemm's canal dimensions and outflow facility.
    Allingham RR; de Kater AW; Ethier CR
    Exp Eye Res; 1996 Jan; 62(1):101-9. PubMed ID: 8674505
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632.
    Rao PV; Deng PF; Kumar J; Epstein DL
    Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1029-37. PubMed ID: 11274082
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparisons of Schlemm's canal and trabecular meshwork morphologies between juvenile and primary open angle glaucoma.
    Hamanaka T; Sakurai T; Fuse N; Ishida N; Kumasaka T; Tanito M
    Exp Eye Res; 2021 Sep; 210():108711. PubMed ID: 34352267
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacology of novel intraocular pressure-lowering targets that enhance conventional outflow facility: Pitfalls, promises and what lies ahead?
    Prasanna G; Li B; Mogi M; Rice DS
    Eur J Pharmacol; 2016 Sep; 787():47-56. PubMed ID: 26948313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of topical TGF-β1, TGF-β2, ATX, and LPA on IOP elevation and regulation of the conventional aqueous humor outflow pathway.
    Nakamura N; Yamagishi R; Honjo M; Igarashi N; Shimizu S; Aihara M
    Mol Vis; 2021; 27():61-77. PubMed ID: 33633440
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Morphological changes in the trabecular meshwork and Schlemm's canal after treatment with topical intraocular pressure-lowering agents.
    Park JH; Chung HW; Yoon EG; Ji MJ; Yoo C; Kim YY
    Sci Rep; 2021 Sep; 11(1):18169. PubMed ID: 34518638
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting VE-PTP phosphatase protects the kidney from diabetic injury.
    Carota IA; Kenig-Kozlovsky Y; Onay T; Scott R; Thomson BR; Souma T; Bartlett CS; Li Y; Procissi D; Ramirez V; Yamaguchi S; Tarjus A; Tanna CE; Li C; Eremina V; Vestweber D; Oladipupo SS; Breyer MD; Quaggin SE
    J Exp Med; 2019 Apr; 216(4):936-949. PubMed ID: 30886059
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute Effects of Intraocular Pressure-Induced Changes in Schlemm's Canal Morphology on Outflow Facility in Healthy Human Eyes.
    Chen W; Hu T; Xu Q; Chen Z; Zhang H; Wang J
    Invest Ophthalmol Vis Sci; 2020 Jul; 61(8):36. PubMed ID: 32716504
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of protein kinase inhibitor, HA1077, on intraocular pressure and outflow facility in rabbit eyes.
    Honjo M; Inatani M; Kido N; Sawamura T; Yue BY; Honda Y; Tanihara H
    Arch Ophthalmol; 2001 Aug; 119(8):1171-8. PubMed ID: 11483085
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impaired angiopoietin/Tie2 signaling compromises Schlemm's canal integrity and induces glaucoma.
    Kim J; Park DY; Bae H; Park DY; Kim D; Lee CK; Song S; Chung TY; Lim DH; Kubota Y; Hong YK; He Y; Augustin HG; Oliver G; Koh GY
    J Clin Invest; 2017 Oct; 127(10):3877-3896. PubMed ID: 28920924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of vascular-endothelial protein tyrosine phosphatase inhibition on breast cancer vasculature and metastatic progression.
    Goel S; Gupta N; Walcott BP; Snuderl M; Kesler CT; Kirkpatrick ND; Heishi T; Huang Y; Martin JD; Ager E; Samuel R; Wang S; Yazbek J; Vakoc BJ; Peterson RT; Padera TP; Duda DG; Fukumura D; Jain RK
    J Natl Cancer Inst; 2013 Aug; 105(16):1188-201. PubMed ID: 23899555
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacologic disruption of Schlemm's canal cells and outflow facility in anterior segments of human eyes.
    Bahler CK; Hann CR; Fautsch MP; Johnson DH
    Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2246-54. PubMed ID: 15223802
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endothelial Tyrosine Kinase Tie1 Is Required for Normal Schlemm's Canal Development-Brief Report.
    Du J; Thomson BR; Onay T; Quaggin SE
    Arterioscler Thromb Vasc Biol; 2022 Mar; 42(3):348-351. PubMed ID: 35021855
    [TBL] [Abstract][Full Text] [Related]  

  • 54. All TIEd up: mechanisms of Schlemm's canal maintenance.
    Bernier-Latmani J; Petrova TV
    J Clin Invest; 2017 Oct; 127(10):3594-3597. PubMed ID: 28920923
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aerobic exercise reduces intraocular pressure and expands Schlemm's canal dimensions in healthy and primary open-angle glaucoma eyes.
    Yuan Y; Lin TPH; Gao K; Zhou R; Radke NV; Lam DSC; Zhang X
    Indian J Ophthalmol; 2021 May; 69(5):1127-1134. PubMed ID: 33402660
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TIE2 expression in hypertensive ICH and its therapeutic modulation with AKB-9778: Implications for brain vascular health.
    Wu J; Wang H; Wang N; Wang Z; Zhu Q
    Exp Neurol; 2024 Apr; 374():114685. PubMed ID: 38195021
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Histopathology of the trabecular meshwork and Schlemm's canal in primary angle-closure glaucoma.
    Hamanaka T; Kasahara K; Takemura T
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8849-61. PubMed ID: 21960557
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deconstructing aqueous humor outflow - The last 50 years.
    Kaufman PL
    Exp Eye Res; 2020 Aug; 197():108105. PubMed ID: 32590004
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The ocular pulse decreases aqueous humor outflow resistance by stimulating nitric oxide production.
    Madekurozwa M; Stamer WD; Reina-Torres E; Sherwood JM; Overby DR
    Am J Physiol Cell Physiol; 2021 Apr; 320(4):C652-C665. PubMed ID: 33439773
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Physiologic Consequences of Caveolin-1 Ablation in Conventional Outflow Endothelia.
    De Ieso ML; Gurley JM; McClellan ME; Gu X; Navarro I; Li G; Gomez-Caraballo M; Enyong E; Stamer WD; Elliott MH
    Invest Ophthalmol Vis Sci; 2020 Sep; 61(11):32. PubMed ID: 32940661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.